Abstract
Interleukin 1β (IL-1β) is a key orchestrator of inflammation and host defense that exerts its effects through IL-1 receptor type I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). How IL-1RAcP is recruited by IL-1β–IL-1RI to form the signaling-competent complex remains elusive. Here we present the crystal structure of IL-1β bound to IL-1 receptor type II (IL-1RII) and IL-1RAcP. IL-1β–IL-1RII generated a composite binding surface to recruit IL-1RAcP. Biochemical analysis demonstrated that IL-1β–IL-1RI and IL-1β–IL-1RII interacted similarly with IL-1RAcP. It also showed the importance of two loops of IL-1 receptor antagonist (IL-1Ra) in determining its antagonism. Our results provide a structural basis for assembly and activation of the IL-1 receptor and offer a general cytokine-receptor architecture that governs the IL-1 family of cytokines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dinarello, C.A. Biologic basis for interleukin-1 in disease. Blood 87, 2095–2147 (1996).
Barksby, H.E., Lea, S.R., Preshaw, P.M. & Taylor, J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149, 217–225 (2007).
Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519–550 (2009).
Sims, J.E. & Smith, D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89–102 (2010).
Sims, J.E. et al. A new nomenclature for IL-1-family genes. Trends Immunol. 22, 536–537 (2001).
Dinarello, C.A. IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 40, 599–606 (2010).
Auron, P.E. et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. USA 81, 7907–7911 (1984).
Lomedico, P.T. et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312, 458–462 (1984).
March, C.J. et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315, 641–647 (1985).
Dinarello, C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20, S1–S13 (2002).
Braddock, M. & Quinn, A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3, 330–339 (2004).
Dinarello, C.A. The many worlds of reducing interleukin-1. Arthritis Rheum. 52, 1960–1967 (2005).
Goldbach-Mansky, R. Blocking interleukin-1 in rheumatic diseases. Ann. NY Acad. Sci. 1182, 111–123 (2009).
Sims, J.E. et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241, 585–589 (1988).
Greenfeder, S.A. et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270, 13757–13765 (1995).
Korherr, C., Hofmeister, R., Wesche, H. & Falk, W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27, 262–267 (1997).
Cullinan, E.B. et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J. Immunol. 161, 5614–5620 (1998).
Dunne, A. & O'Neill, L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 171, re3 (2003).
McMahan, C.J. et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 2821–2832 (1991).
Colotta, F. et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472–475 (1993).
Colotta, F., Dower, S.K., Sims, J.E. & Mantovani, A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15, 562–566 (1994).
Lang, D. et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161, 6871–6877 (1998).
Malinowsky, D., Lundkvist, J., Laye, S. & Bartfai, T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429, 299–302 (1998).
Boraschi, D. & Tagliabue, A. The interleukin-1 receptor family. Vitam. Horm. 74, 229–254 (2006).
Smith, D.E. et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18, 87–96 (2003).
Vigers, G.P., Anderson, L.J., Caffes, P. & Brandhuber, B.J. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β. Nature 386, 190–194 (1997).
Schreuder, H. et al. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386, 194–200 (1997).
Boraschi, D., Bossu, P., Macchia, G., Ruggiero, P. & Tagliabue, A. Structure-function relationship in the IL-1 family. Front. Biosci. 1, d270–d308 (1996).
Vigers, G.P., Dripps, D.J., Edwards, C.K. III & Brandhuber, B.J. X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. J. Biol. Chem. 275, 36927–36933 (2000).
Casadio, R. et al. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1β/IL-1R(I) complex. FEBS Lett. 499, 65–68 (2001).
Lingel, A. et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors–insight into heterotrimeric IL-1 signaling complexes. Structure 17, 1398–1410 (2009).
Yoon, D.Y. & Dinarello, C.A. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J. Immunol. 160, 3170–3179 (1998).
Simoncsits, A. et al. Deletion mutants of human interleukin 1β with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors. Cytokine 6, 206–214 (1994).
Ju, G. et al. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc. Natl. Acad. Sci. USA 88, 2658–2662 (1991).
D'Ettorre, C., De Chiara, G., Casadei, R., Boraschi, D. & Tagliabue, A. Functional epitope mapping of human interleukin-1β by surface plasmon resonance. Eur. Cytokine Netw. 8, 161–171 (1997).
Greenfeder, S.A. et al. Insertion of a structural domain of interleukin (IL)-1β confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. J. Biol. Chem. 270, 22460–22466 (1995).
Kawashima, H. et al. Structure-activity relationships in human interleukin-1α: identification of key residues for expression of biological activities. Protein Eng. 5, 171–176 (1992).
Torigoe, K. et al. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272, 25737–25742 (1997).
Born, T.L., Thomassen, E., Bird, T.A. & Sims, J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273, 29445–29450 (1998).
Kato, Z. et al. The structure and binding mode of interleukin-18. Nat. Struct. Biol. 10, 966–971 (2003).
Kim, S.H. et al. Identification of amino acid residues critical for biological activity in human interleukin-18. J. Biol. Chem. 277, 10998–11003 (2002).
Kim, S.H. et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA 97, 1190–1195 (2000).
Krumm, B., Meng, X., Li, Y., Xiang, Y. & Deng, J. Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc. Natl. Acad. Sci. USA 105, 20711–20715 (2008).
Argiriadi, M.A., Xiang, T., Wu, C., Ghayur, T. & Borhani, D.W. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18. J. Biol. Chem. 284, 24478–24489 (2009).
Wang, X., Lupardus, P., Laporte, S.L. & Garcia, K.C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27, 29–60 (2009).
Leslie, A. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 26 (1992).
Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763 (1994).
Strong, M. et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 8060–8065 (2006).
McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007).
Priestle, J.P., Schar, H.P. & Grutter, M.G. Crystallographic refinement of interleukin 1β at 2.0 Å resolution. Proc. Natl. Acad. Sci. USA 86, 9667–9671 (1989).
Schneider, T.R. & Sheldrick, G.M. Substructure solution with SHELXD. Acta Crystallogr. D Biol. Crystallogr. 58, 1772–1779 (2002).
Adams, P.D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948–1954 (2002).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Brunger, A.T. Version 1.2 of the Crystallography and NMR system. Nat. Protocols 2, 2728–2733 (2007).
DeLano, W.L. Pymol Molecular Graphics System (DeLano Scientific, San Carlos, California, 2002).
Acknowledgements
We thank J.W. Wang and H.P. Gong for assistance with structure determination; J.H. He, S. Huang and L. Tang at Shanghai Synchrotron Research Facility beamline BL-17U for help with data collection; Y.Y. Chen and X.D. Zhao for technical help with BIAcore 3000 at the Institute of Biophysics, Chinese Academy of Sciences; and Y.G. Shi, H.T. Li, L. Yu, N. Yan, M.J. Yang, J.W. Wu, Y.H. Chen and Z. Wang for discussion. Supported by Tsinghua University 985 Phase II funds, the Ministry of Science and Technology (2010CB912402), the Ministry of Health (2008ZX10001-011) and the Fok Ying Tung Education Foundation.
Author information
Authors and Affiliations
Contributions
D.W. purified protein, grew crystals, collected diffraction data, did BIAcore experiments, analyzed data and contributed to the writing of the manuscript; S.Z. made baculoviruses and cultured insect cells; L.L., X.L. and K.M. were involved in protein purification; and X.W. collected diffraction data, solved structure, analyzed data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6 and Supplementary Table 1 (PDF 963 kb)
Rights and permissions
About this article
Cite this article
Wang, D., Zhang, S., Li, L. et al. Structural insights into the assembly and activation of IL-1β with its receptors. Nat Immunol 11, 905–911 (2010). https://doi.org/10.1038/ni.1925
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.1925
This article is cited by
-
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β
Nature Communications (2023)
-
Immune cells lacking Y chromosome show dysregulation of autosomal gene expression
Cellular and Molecular Life Sciences (2021)
-
Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors
Scientific Reports (2020)
-
The IL-1 family of cytokines and receptors in rheumatic diseases
Nature Reviews Rheumatology (2019)
-
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein
Scientific Reports (2019)